International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium

Biology of Blood and Marrow Transplantation

Volumn 22, Issue 1, 2016, Pages 4-10

  Harris, Andrew C ^a,b   Young, Rachel ^a,c   Devine, Steven ^d   Hogan, William J ^e   Ayuk, Francis ^f   Bunworasate, Udomsak ^g   Chanswangphuwana, Chantiya ^g   Efebera, Yvonne A ^d   Holler, Ernst ^h   Litzow, Mark ^e   Ordemann, Rainer ⁱ   Qayed, Muna ^j   Renteria, Anne S ^c   Reshef, Ran ^k   Wölfl, Matthias ^l   Chen, Yi Bin ^m   Goldstein, Steven ^a   Jagasia, Madan ⁿ   Locatelli, Franco ^o   Mielke, Stephan ^l   Porter, David ^p   Schechter, Tal ^q   Shekhovtsova, Zhanna ^r   Ferrara, James L M ^c   Levine, John E ^a,c   more..

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e MAYO CLINIC   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g CHULALONGKORN UNIVERSITY   (Thailand)

^h UNIVERSITY OF REGENSBURG   (Germany)

ⁱ UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^j CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^k Department of Medicine   (United States)

^l UNIVERSITY OF WÜRZBURG   (Germany)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^o BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

^q HOSPITAL FOR SICK CHILDREN   (Canada)

^r Federal Research and Clinical Center of Pediatric Hematology   (Russian Federation)

more..

Author keywords

BMT; Bone marrow transplant; Graft versus host disease; Guidance; Guidelines; GVHD; Staging; Standardization

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BIOPSY; DATA COLLECTION METHOD; HUMAN; INTESTINE; LIVER; MORBIDITY; MORTALITY; MULTICENTER STUDY (TOPIC); PHENOTYPE; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPRODUCIBILITY; SKIN; STANDARDIZATION; TARGET ORGAN; UPPER GASTROINTESTINAL TRACT; ACUTE DISEASE; ALLOGRAFT; CLINICAL TRIAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MULTICENTER STUDY;

ACUTE DISEASE; ALLOGRAFTS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84952639431     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2015.09.001     Document Type: Article

References (27)

1. Weisdorf D.J., Hurd D., Carter S., et al. Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biol Blood Marrow Transplant 2003, 9:512-518.
2. Atkinson K., Horowitz M.M., Biggs J.C., et al. The clinical diagnosis of acute graft-versus-host disease: a diversity of views amongst marrow transplant centers. Bone Marrow Transplant 1988, 3:5-10.
3. MacMillan M.L., Weisdorf D.J., Wagner J.E., et al. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant 2002, 8:387-394.
4. Gooley T.A., Chien J.W., Pergam S.A., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010, 363:2091-2101.
5. Levine J.E., Hogan W.J., Harris A.C., et al. Improved accuracy of acute graft-versus-host disease staging among multiple centers. Best Pract Res Clin Haematol 2014, 27:283-287.
6. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995, 15:825-828.
7. MacMillan M.L., Robin M., Harris A.C., et al. A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality. Biol Blood Marrow Transplant 2015, 21:761-767.
8. Ferrara J.L., Levine J.E., Reddy P., Holler E. Graft-versus-host disease. Lancet 2009, 373:1550-1561.
9. Wallace A.B. The exposure treatment of burns. Lancet 1951, 1:501-504.
10. Levine J.E., Braun T.M., Harris A.C., et al. A prognostic score for acute graft-versus-host disease based on biomarkers: a multicenter study. Lancet Haematol 2015, 2:e21-e29.
11. Leisenring W.M., Martin P.J., Petersdorf E.W., et al. An acute graft-versus-host disease activity index to predict survival after hematopoietic cell transplantation with myeloablative conditioning regimens. Blood 2006, 108:749-755.
12. Robin M., Porcher R., de Castro R., et al. Initial liver involvement in acute GVHD is predictive for nonrelapse mortality. Transplantation 2009, 88:1131-1136.
13. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
14. Thomas E.D., Storb R., Clift C.D., et al. Bone-marrow transplantation. N Engl J Med 1975, 292(Pt. 2):895-902.
15. Martin P.J., McDonald G.B., Sanders J.E., et al. Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2004, 10:320-327.
16. Weisdorf D., Snover D., Haake R., et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy. Blood 1990, 76:624-629.
17. Castilla-Llorente C., Martin P.J., McDonald G.B., et al. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2014, 49:966-971.
18. Abraham J., Janin A., Gornet J.M., et al. Clinical severity scores in gastrointestinal graft-versus-host disease. Transplantation 2014, 97:965-971.
19. Nevo S., Enger C., Swan V., et al. Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival. Transplantation 1999, 67:681-689.
20. Shulman H.M., Kleiner D., Lee S.J., et al. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. II. Pathology Working Group Report. Biol Blood Marrow Transplant 2006, 12:31-47.
21. Kuykendall T.D., Smoller B.R. Lack of specificity in skin biopsy specimens to assess for acute graft-versus-host disease in initial 3 weeks after bone-marrow transplantation. J Am Acad Dermatol 2003, 49:1081-1085.
22. Massi D., Fondi C., Nozzoli C., et al. The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo. Hum Pathol 2011, 42:254-268.
23. Ho V.T., Cutler C. Current and novel therapies in acute GVHD. Best Pract Res Clin Haematol 2008, 21:223-237.
24. Martin P.J., Inamoto Y., Flowers M.E., Carpenter P.A. Secondary treatment of acute graft-versus-host disease: a critical review. Biol Blood Marrow Transplant 2012, 18:982-988.
25. Xhaard A., Rocha V., Bueno B., et al. Steroid-refractory acute GVHD: lack of long-term improved survival using new generation anticytokine treatment. Biol Blood Marrow Transplant 2012, 18:406-413.
26. Ruutu T., Gratwohl A., de Witte T., et al. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice. Bone Marrow Transplant 2014, 49:168-173.
27. Bolanos-Meade J., Logan B.R., Alousi A.M., et al. Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802. Blood 2014, 124:3221-3227.